Form 4: Walgreens Boots Alliance Executive Chairman Stefano Pessina Reports Stock Award Vesting and Dividend Equivalent Shares
SEC Form 4
Stefano Pessina, Executive Chairman of Walgreens Boots Alliance, reports the vesting of restricted stock awards and acquisition of dividend equivalent shares, along with holdings of common stock and employee stock options.
Summary
- On October 23, 2024, Stefano Pessina, Executive Chairman of Walgreens Boots Alliance, reported the vesting of 374,883 shares of common stock due to the satisfaction of performance criteria related to a restricted stock award granted on November 1, 2023.
- These shares will vest on November 1, 2026, subject to forfeiture under the terms of the 2021 Omnibus Incentive Plan.
- Pessina also reported the acquisition of 58,413 shares underlying restricted stock units issued in lieu of dividends on outstanding restricted stock units from October 27, 2023, through October 25, 2024.
- Following these transactions, Pessina directly owns 1,490,561 shares of common stock and indirectly owns 144,788,821 shares through Alliance Sante Participations S.A. (ASP).
- Pessina also holds employee stock options for a total of 1,993,920 shares at various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing. The vesting of stock awards suggests positive performance, but the overall sentiment is neutral.
Positives
- The vesting of restricted stock awards indicates that performance criteria were met, which could be viewed positively.
- The acquisition of dividend equivalent shares suggests a continued investment in the company's success.
Risks
- The vested shares are subject to forfeiture under certain circumstances, indicating potential risks associated with continued employment or performance.
- The value of the stock options is dependent on the future performance of Walgreens Boots Alliance's stock price.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting of restricted stock and continued option holdings suggest an expectation of future value creation.
Industry Context
Executive stock ownership and option grants are common practices in publicly traded companies to align management's interests with those of shareholders. This filing is a routine disclosure related to these practices.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock, are standard practice among large, publicly traded companies like Walgreens Boots Alliance.
- Companies like CVS Health and Rite Aid also utilize similar equity-based compensation to incentivize their executives.
- The size and structure of these packages are typically benchmarked against peer companies in the retail pharmacy and healthcare sectors.
Stakeholder Impact
- The vesting of stock awards and option holdings can impact shareholder value depending on the company's future performance.
- Executive compensation practices can influence employee morale and perceptions of fairness.
Key Dates
| Date | Description |
|---|---|
| 02/12/2019 | Employee Stock Option (right to buy) $ 77.08 vested on this date |
| 11/01/2019 | Employee Stock Option (right to buy) $ 82.46 vested on this date |
| 11/01/2019 | Employee Stock Option (right to buy) $ 79.9 vested with respect to 131,555 shares on this date |
| 11/01/2020 | Employee Stock Option (right to buy) $ 57.38 vested with respect to 139,916 shares on this date |
| 11/01/2023 | Date of restricted stock award grant |
| 10/23/2024 | Date of determination that performance criteria were met for restricted stock award |
| 10/25/2024 | Date of report |
| 11/01/2026 | Date of vesting for restricted stock awards |
| 02/12/2026 | Expiration Date of Employee Stock Option (right to buy) $ 77.08 |
| 11/01/2026 | Expiration Date of Employee Stock Option (right to buy) $ 82.46 |
| 11/01/2027 | Expiration Date of Employee Stock Option (right to buy) $ 67.01 |
| 11/01/2028 | Expiration Date of Employee Stock Option (right to buy) $ 79.9 |
| 11/01/2029 | Expiration Date of Employee Stock Option (right to buy) $ 57.38 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.